WordPress WooCommerce Themes

Success Stories

Helping Microbio take life-saving science to the world

Industry
Health, Science

Service
Technology Services,  Organisational Strategy, Business Analysis

Client background

Sepsis is a life-threatening condition that occurs when infection causes the body’s vital organs to shut down. It’s a leading cause of death worldwide — and for those who survive, the long-term impacts can be life-changing.

Speed is critical when treating bloodstream infections like sepsis. The faster clinicians can identify what’s causing the infection, the sooner they can treat it — and the better the chance of recovery. But bloodstream infections can be hard to diagnose. Blood cultures can take up to 72 hours to deliver results. In the meantime, clinicians often have to rely on “best guess” antibiotics.

Australian biotech company Microbio is changing that.
Their rapid diagnostic test, InfectID™-BSI, can detect 26 sepsis-associated bacteria and yeast species directly from a small blood sample — and deliver results in just 3 hours.
That means faster answers, more targeted treatment, and better outcomes for patients.

The challenge

As a research-led organisation, Microbio had developed an exceptional product with huge potential. Their breakthrough technology was ready to move beyond the lab.

The next step was turning that innovation into a commercially viable offering — without losing the scientific rigour and purpose that drove it. To do that, Microbio needed to:

  • Strengthen their IT and data capabilities
  • Streamline how their product was delivered
  • Build systems that could support growth, compliance and ongoing development.

And, most importantly, do it in a way that stayed true to who they are — practical, innovative, and driven by impact.

Our approach

We partnered with Microbio to support this shift from research to commercial operations, working closely with their team to make sure everything stayed aligned to their vision and goals.

We started by building a clear picture of where they were now — looking across people, processes, technology, and product delivery.
From there, we worked together to design where they wanted to be — and what would need to change to get there.

This included:

  • Running future-state vision workshops
  • Reviewing their software development lifecycle (SDLC)
  • Assessing their technical code for scalability and maintainability
  • Analysing their data capability and readiness

Using these insights, we developed:

  • High-level technical designs to support future development
  • A data strategy to guide how information is captured, managed and used
  • An IT investment roadmap to help plan for growth, resourcing, and compliance.

All of this came together in a practical, actionable plan — designed to support scale without unnecessary complexity.

Outcomes and benefits

Microbio’s groundbreaking science is changing the way infections are diagnosed. Our role was to support them in bringing that innovation to market, faster and with confidence.

With InfectID™-BSI, Microbio is bringing breakthrough science out of the lab and into the hands of clinicians — giving them faster, more accurate answers when it matters most.

Our work helped Microbio lay the technology and data foundations needed to scale that innovation and get it ready for the real world.

Tangible outcomes included:

  • High-level technical designs to guide future system development
  • A data strategy tailored to Microbio’s needs
  • An IT investment plan to support future growth and compliance.

Impact beyond technical deliverables:

  • Leadership alignment around a clear vision for scaling
  • Greater clarity on system gaps, risks and priorities
  • Increased organisational confidence in bringing their product to market.

Ultimately, this work supported Microbio’s mission: helping clinicians act faster, treat more accurately, and reduce unnecessary antibiotic use. This means improving patient outcomes and easing pressure on healthcare systems too.

With sepsis claiming 11 million lives globally each year, InfectID™-BSI is exactly the kind of innovation the world needs.

 

Discover more about Microbio and their incredible work here: microbio.com.au

Related Success Stories

Comments are closed

Follow us

@ bdna Group | All rights reserved | Privacy Policy
Eugene Brink
Chief Delivery Officer
Linkedin

An advocate for technology and innovation, Eugene has extensive experience in analysing, designing, and delivering enterprise solutions in complex environments.

With a background in State and Federal Government, he’s recognised for bridging the gap between technical and business needs, driven by a belief that anything is achievable with the right approach.

As bdna’s Chief Delivery Officer, Eugene leads delivery excellence, creating impactful solutions for a safer, healthier future.

Leigh Johnston
Chief Commercial Officer

Linkedin

With over 20 years of experience in business consulting and development across the UK and Australia, Leigh has guided clients from diverse industries in adopting best-practice tools and strategies to gain a competitive edge.
 
As bdna’s Chief Commercial Officer, she leads enterprise business development and customer relationship management, driving improvements in business performance and sales effectiveness.
 
Her approach has consistently helped clients boost market share, enhance customer satisfaction, and increase employee engagement.

Henry Vesander
Chief Product Officer

Linkedin

Henry combines a passion for technology with extensive experience in product management, customer success, and channel management.
 
Trusted to drive growth and digital transformation, he has a strong track record in developing innovative products and go-to-market strategies.

As bdna’s Chief Product Officer, Henry leads our product vision, focusing on our SaaS Public Safety Suite to ensure we meet—and exceed—the evolving needs of our clients, ensuring we deliver maximum value through strategic innovation.

Karyn Smith
Chief Operating Officer

Linkedin

With over 30 years of international, cross-industry experience, Karyn excels in strategic planning, organisational transformation, and performance improvement.
 
As bdna’s Chief Operating Officer, she oversees people, brand, and finances, keeping the company humming, healthy, and happy. Known for her dynamic leadership and strong communication skills, Karyn motivates and empowers teams to deliver sustainable, impactful results.
 
Passionate about making a difference, she focuses on not only achieving outcomes but also ensuring they’re delivered with care and respect for those involved.

Marty Wauchope
Chief Technology Officer

Linkedin

A founding member of bdna, Marty brings over 30 years of global consulting experience across public safety, utilities, mining, construction, eHealth, and commercial sectors.

As bdna’s Chief Technology Officer, he focusses on risk management, information security, and technology compliance to ensure bdna remains safe and resilient.

Known for delivering high-quality, transformative outcomes, Marty uses his deep industry knowledge to drive impactful solutions that help our clients navigate complex challenges with confidence.

Ryan Sheppard
Chief Executive Officer
Linkedin

Ryan, CO-founder and CEO of bdna, brings over three decades of leadership experience in commercial and public sectors across Australia and globally.

Known for spearheading large-scale transformation initiatives, he actively drives bdna’s vision while fostering a culture of mentorship and innovation.

With a strategic focus on sustainable growth, Ryan collaborates across industries, including health, law enforcement, and nonprofits, to deliver impact-driven results.